• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Cabenuva

GSK
Pharma

GSK allows generic versions of cabotegravir for HIV treatment

GSK has expanded its agreement with the Medicines Patent Pool, allowing generic production of cabotegravir as an HIV treatment in poorer nations.
Kevin Dunleavy Jul 15, 2025 2:16pm
drug launch

Vyvgart, Cabenuva, Lumakras top Trinity launch success analysis

Mar 12, 2025 2:13pm
Apretude

GSK bolsters case for long-acting HIV PrEP drug Apretude

Oct 16, 2024 1:26pm
Apretude US vial

GSK to triple long-acting Apretude supply to boost global access

Oct 7, 2024 10:56am
Blue Cross Blue Shield of NC removes HIV drugs from costly price tiers

WHO flags increasing resistance to GSK's Tivicay in 4 countries

Mar 6, 2024 2:02pm
GSK

GSK's long-acting HIV med beats daily pills in some patients

Feb 21, 2024 2:00am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings